Mesenchymal Stromal Cells Derived From Crohn's Patients Deploy Indoleamine 2,3-dioxygenase-mediated Immune Suppression, Independent of Autophagy

Autologous bone marrow-derived mesenchymal stromal cells (MSCs) for adoptive cell therapy of luminal Crohn's disease (CD) are being tested in clinical trials. However, CD is associated with dysregulation of autophagy and its effect on MSC's immunobiology is unknown. Here, we demonstrate no...

Full description

Saved in:
Bibliographic Details
Published inMolecular therapy Vol. 23; no. 7; pp. 1248 - 1261
Main Authors Chinnadurai, Raghavan, Copland, Ian B, Ng, Spencer, Garcia, Marco, Prasad, Mahadev, Arafat, Dalia, Gibson, Greg, Kugathasan, Subra, Galipeau, Jacques
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.07.2015
Elsevier Limited
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Autologous bone marrow-derived mesenchymal stromal cells (MSCs) for adoptive cell therapy of luminal Crohn's disease (CD) are being tested in clinical trials. However, CD is associated with dysregulation of autophagy and its effect on MSC's immunobiology is unknown. Here, we demonstrate no quantitative difference in phenotype, in vitro growth kinetics and molecular signatures to IFNγ between MSCs derived from CD and healthy individuals. CD MSCs were indistinguishable from those derived from healthy controls at inhibiting T-cell proliferation through an indoleamine 2,3-dioxygenase (IDO)-dependent mechanism. Upon IFNγ prelicensing, both MSC populations inhibit T-cell effector functions. Neither a single-nucleotide polymorphism (SNP) rs7820268 in the IDO gene, nor a widely reported CD predisposing SNP ATG16L1rs2241880 modulated the suppressive function of MSCs carrying these haplotypes. IFNγ stimulation or coculture with activated T cells upregulated the expression of autophagy genes and/or vacuoles on MSCs. Pharmacological blockade of autophagy pathway did not reverse the immunosuppressive properties and IFNγ responsiveness of MSCs confirming the absence of a functional link between these two cell biochemical properties. We conclude that autophagy, but not IDO and IFNγ responsiveness, is dispensable for MSC's immunosuppressive properties. MSCs from CD subjects are functionally analogous to those of healthy individuals.
AbstractList Autologous bone marrow-derived mesenchymal stromal cells (MSCs) for adoptive cell therapy of luminal Crohn's disease (CD) are being tested in clinical trials. However, CD is associated with dysregulation of autophagy and its effect on MSC's immunobiology is unknown. Here, we demonstrate no quantitative difference in phenotype, in vitro growth kinetics and molecular signatures to IFNγ between MSCs derived from CD and healthy individuals. CD MSCs were indistinguishable from those derived from healthy controls at inhibiting T-cell proliferation through an indoleamine 2,3-dioxygenase (IDO)-dependent mechanism. Upon IFNγ prelicensing, both MSC populations inhibit T-cell effector functions. Neither a single-nucleotide polymorphism (SNP) rs7820268 in the IDO gene, nor a widely reported CD predisposing SNP ATG16L1rs2241880 modulated the suppressive function of MSCs carrying these haplotypes. IFNγ stimulation or coculture with activated T cells upregulated the expression of autophagy genes and/or vacuoles on MSCs. Pharmacological blockade of autophagy pathway did not reverse the immunosuppressive properties and IFNγ responsiveness of MSCs confirming the absence of a functional link between these two cell biochemical properties. We conclude that autophagy, but not IDO and IFNγ responsiveness, is dispensable for MSC's immunosuppressive properties. MSCs from CD subjects are functionally analogous to those of healthy individuals.
Autologous bone marrow-derived mesenchymal stromal cells (MSCs) for adoptive cell therapy of luminal Crohn's disease (CD) are being tested in clinical trials. However, CD is associated with dysregulation of autophagy and its effect on MSC's immunobiology is unknown. Here, we demonstrate no quantitative difference in phenotype, in vitro growth kinetics and molecular signatures to IFNγ between MSCs derived from CD and healthy individuals. CD MSCs were indistinguishable from those derived from healthy controls at inhibiting T-cell proliferation through an indoleamine 2,3-dioxygenase (IDO)-dependent mechanism. Upon IFNγ prelicensing, both MSC populations inhibit T-cell effector functions. Neither a single-nucleotide polymorphism (SNP) rs7820268 in the IDO gene, nor a widely reported CD predisposing SNP ATG16L1rs2241880 modulated the suppressive function of MSCs carrying these haplotypes. IFNγ stimulation or coculture with activated T cells upregulated the expression of autophagy genes and/or vacuoles on MSCs. Pharmacological blockade of autophagy pathway did not reverse the immunosuppressive properties and IFNγ responsiveness of MSCs confirming the absence of a functional link between these two cell biochemical properties. We conclude that autophagy, but not IDO and IFNγ responsiveness, is dispensable for MSC's immunosuppressive properties. MSCs from CD subjects are functionally analogous to those of healthy individuals.
Autologous bone marrow-derived mesenchymal stromal cells (MSCs) for adoptive cell therapy of luminal Crohn's disease (CD) are being tested in clinical trials. However, CD is associated with dysregulation of autophagy and its effect on MSC's immunobiology is unknown. Here, we demonstrate no quantitative difference in phenotype, in vitro growth kinetics and molecular signatures to IFN[gamma] between MSCs derived from CD and healthy individuals. CD MSCs were indistinguishable from those derived from healthy controls at inhibiting T-cell proliferation through an indoleamine 2,3-dioxygenase (IDO)-dependent mechanism. Upon IFN[gamma] prelicensing, both MSC populations inhibit T-cell effector functions. Neither a single-nucleotide polymorphism (SNP) rs7820268 in the IDO gene, nor a widely reported CD predisposing SNP ATG16L1rs2241880 modulated the suppressive function of MSCs carrying these haplotypes. IFN[gamma] stimulation or coculture with activated T cells upregulated the expression of autophagy genes and/or vacuoles on MSCs. Pharmacological blockade of autophagy pathway did not reverse the immunosuppressive properties and IFN[gamma] responsiveness of MSCs confirming the absence of a functional link between these two cell biochemical properties. We conclude that autophagy, but not IDO and IFN[gamma] responsiveness, is dispensable for MSC's immunosuppressive properties. MSCs from CD subjects are functionally analogous to those of healthy individuals.
Author Arafat, Dalia
Kugathasan, Subra
Garcia, Marco
Gibson, Greg
Copland, Ian B
Galipeau, Jacques
Ng, Spencer
Prasad, Mahadev
Chinnadurai, Raghavan
Author_xml – sequence: 1
  givenname: Raghavan
  surname: Chinnadurai
  fullname: Chinnadurai, Raghavan
  organization: Department of Hematology and Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia, USA
– sequence: 2
  givenname: Ian B
  surname: Copland
  fullname: Copland, Ian B
  organization: Department of Hematology and Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia, USA
– sequence: 3
  givenname: Spencer
  surname: Ng
  fullname: Ng, Spencer
  organization: Department of Hematology and Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia, USA
– sequence: 4
  givenname: Marco
  surname: Garcia
  fullname: Garcia, Marco
  organization: Emory Healthcare, Atlanta, Georgia, USA
– sequence: 5
  givenname: Mahadev
  surname: Prasad
  fullname: Prasad, Mahadev
  organization: Department of Pediatrics, Emory University, Atlanta, Georgia, USA
– sequence: 6
  givenname: Dalia
  surname: Arafat
  fullname: Arafat, Dalia
  organization: School of Biology, Georgia Institute of Technology, Atlanta, Georgia, USA
– sequence: 7
  givenname: Greg
  surname: Gibson
  fullname: Gibson, Greg
  organization: School of Biology, Georgia Institute of Technology, Atlanta, Georgia, USA
– sequence: 8
  givenname: Subra
  surname: Kugathasan
  fullname: Kugathasan, Subra
  organization: Department of Pediatrics, Emory University, Atlanta, Georgia, USA
– sequence: 9
  givenname: Jacques
  surname: Galipeau
  fullname: Galipeau, Jacques
  email: jgalipe@emory.edu
  organization: Department of Hematology and Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25899824$$D View this record in MEDLINE/PubMed
BookMark eNqFUttq3DAQNSWlubQv_YBi6ENLibeWrYv1Ugjbpl1IaSF5F1p5vKtgS44kh-5f9JM7ZpPQhkARjAbNOYfRnDnODpx3kGWvSbkgZd18HNKiKglbcPEsOyKsYkVZVvTgISf8MDuO8RozwiR_kR1WrJGyqehR9vs7RHBmuxt0n1-m4Od7CX0f888Q7C20-Tk-5svgt-5dzH_qZMGluTr2fpevXOt70IN1kFenddFa_2u3AacjFAO0VidUWA3DhPXLaRwDxGi9O52JMAIGl3Lf5WdT8uNWb3Yvs-ed7iO8urtPsqvzL1fLb8XFj6-r5dlFYSiXoiBdozldG4xMsnVVU9Ea2nLeEcak7kgJomtbqRnXeBoBumo0ZbI1ghBTn2Sf9rLjtMY-DbYRdK_GYAcddsprq_6tOLtVG3-raEOEkAwF3t8JBH8zQUxqsNHg4LQDP0WFKM4ZJaX8P5TLSrBaVrPq20fQaz8Fh4NAQUnqmgnaIOrN380_dH1vKwLKPcAEH2OAThmb0Dk__8X2ipRq3hw1JDVvjuICKR8eUe5VnwTTPRjQoVsLQUWDa2HQ8AAmqdbbp2h_AGQ316s
CitedBy_id crossref_primary_10_1021_acs_chemrestox_4c00114
crossref_primary_10_1016_j_celrep_2018_02_013
crossref_primary_10_1093_stcltm_szac050
crossref_primary_10_3390_cells9020431
crossref_primary_10_1016_j_ymthe_2025_02_003
crossref_primary_10_3389_fcell_2020_00447
crossref_primary_10_1093_ibd_izy130
crossref_primary_10_1093_stcltm_szac054
crossref_primary_10_1182_bloodadvances_2017006205
crossref_primary_10_3389_fimmu_2020_00422
crossref_primary_10_1016_j_jcyt_2015_11_008
crossref_primary_10_1093_stcltm_szad003
crossref_primary_10_1111_cei_12929
crossref_primary_10_1158_1541_7786_MCR_19_0509
crossref_primary_10_1186_s13287_020_02121_8
crossref_primary_10_1155_2015_746392
crossref_primary_10_4252_wjsc_v12_i7_688
crossref_primary_10_32604_biocell_2023_042586
crossref_primary_10_3389_fimmu_2019_01228
crossref_primary_10_3389_fcell_2021_715905
crossref_primary_10_1038_s41551_018_0325_8
crossref_primary_10_1089_bioe_2020_0006
crossref_primary_10_1016_j_ejphar_2024_176719
crossref_primary_10_3390_cells11091376
crossref_primary_10_1016_j_bbrc_2024_149591
crossref_primary_10_1038_emm_2017_104
crossref_primary_10_1002_stem_2415
crossref_primary_10_3389_fonc_2020_01632
crossref_primary_10_3389_fphar_2018_00179
crossref_primary_10_3389_fcell_2020_596079
crossref_primary_10_1002_ueg2_12477
crossref_primary_10_1111_apt_13717
crossref_primary_10_1186_s13287_018_0981_3
crossref_primary_10_1186_s40364_019_0156_0
crossref_primary_10_1016_j_jtct_2021_02_002
crossref_primary_10_3390_cells11091503
crossref_primary_10_1093_stmcls_sxae040
crossref_primary_10_3389_fimmu_2022_943333
crossref_primary_10_1016_j_bbmt_2017_01_081
crossref_primary_10_1016_j_autrev_2019_02_004
crossref_primary_10_1016_j_jcyt_2020_09_008
crossref_primary_10_1080_15548627_2019_1630223
crossref_primary_10_1007_s12026_016_8798_6
crossref_primary_10_1016_j_radonc_2024_110093
crossref_primary_10_1186_s13287_021_02645_7
crossref_primary_10_3390_cells8070764
Cites_doi 10.3389/fgene.2012.00243
10.3109/14653240903121260
10.1182/blood-2013-03-491555
10.1016/j.cgh.2013.06.021
10.1002/jcp.24081
10.1073/pnas.1407001111
10.1074/jbc.M109.037671
10.1038/nrgastro.2013.66
10.1007/s00109-012-0934-8
10.1016/j.autrev.2013.10.007
10.1016/j.molmed.2009.03.002
10.1016/j.jcyt.2012.10.002
10.1038/emm.2013.94
10.1038/nature07383
10.1038/mt.2011.189
10.1002/stem.1729
10.1074/jbc.M800266200
10.1007/s12016-012-8347-6
10.3109/14653249.2010.548379
10.1038/nri3209
10.1182/blood-2008-07-166892
10.1080/14653240600855905
10.1182/blood.V99.5.1610
10.1016/j.jcyt.2013.02.010
10.1016/j.stem.2007.11.014
10.1155/2013/929842
10.2174/13894501113146660234
10.1146/annurev.physiol.70.113006.100646
10.1038/nature13044
10.1016/j.ajhg.2011.11.029
10.1016/j.stem.2013.09.006
10.1136/ard.2007.071233
10.4049/jimmunol.179.3.1549
10.1038/ng2032
10.1136/gut.2010.215152
10.1136/gut.2010.228908
10.4049/jimmunol.1301828
10.1016/j.stemcr.2014.05.003
10.1155/2012/826182
10.1093/rheumatology/kel267
10.1038/nature07416
10.1038/mt.2008.296
10.1084/jem.20070906
10.3109/14653249.2011.623691
10.1080/14653240500319234
10.1016/j.humimm.2012.11.008
10.1016/j.biomaterials.2013.06.050
10.1002/ibd.21312
10.1182/blood-2005-03-1004
10.1038/ng1954
ContentType Journal Article
Copyright 2015 American Society of Gene & Cell Therapy
Copyright Nature Publishing Group Jul 2015
Copyright © 2015 American Society of Gene & Cell Therapy 2015 American Society of Gene & Cell Therapy
Copyright_xml – notice: 2015 American Society of Gene & Cell Therapy
– notice: Copyright Nature Publishing Group Jul 2015
– notice: Copyright © 2015 American Society of Gene & Cell Therapy 2015 American Society of Gene & Cell Therapy
DBID 6I.
AAFTH
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M7P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
7X8
7QO
7T5
8FD
FR3
H94
P64
5PM
DOI 10.1038/mt.2015.67
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest SciTech Collection
ProQuest Natural Science Journals
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
ProQuest Health & Medical Collection
Medical Database
ProQuest Biological Science
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
Biotechnology Research Abstracts
Immunology Abstracts
Technology Research Database
Engineering Research Database
AIDS and Cancer Research Abstracts
Biotechnology and BioEngineering Abstracts
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
AIDS and Cancer Research Abstracts
Immunology Abstracts
Engineering Research Database
Biotechnology Research Abstracts
Technology Research Database
Biotechnology and BioEngineering Abstracts
DatabaseTitleList MEDLINE
ProQuest Central Student

AIDS and Cancer Research Abstracts
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1525-0024
EndPage 1261
ExternalDocumentID PMC4817795
4067862091
25899824
10_1038_mt_2015_67
S1525001616301551
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations Atlanta Georgia
United States--US
Georgia
GeographicLocations_xml – name: Atlanta Georgia
– name: United States--US
– name: Georgia
GrantInformation_xml – fundername: NIGMS NIH HHS
  grantid: T32 GM008169
GroupedDBID ---
--K
0R~
123
1B1
29M
2WC
36B
39C
3V.
4.4
53G
6I.
7X7
88E
8FE
8FH
8FI
8FJ
AACTN
AAEDW
AAFTH
AAIAV
AALRI
AAVLU
AAXUO
ABAWZ
ABJNI
ABMAC
ABUDA
ABUWG
ABVKL
ACGFO
ACGFS
ACPRK
ADBBV
ADFRT
ADJPV
ADMUD
ADQMX
AEDAW
AENEX
AFKRA
AFTJW
AGAYW
AHMBA
AITUG
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
AOIJS
ASPBG
AVWKF
AZFZN
BAWUL
BBNVY
BENPR
BHPHI
BPHCQ
BVXVI
CAG
CCPQU
COF
CS3
DIK
DU5
E3Z
EBS
EJD
EMB
EMOBN
F5P
FDB
FEDTE
FRP
FYUFA
GX1
HCIFZ
HMCUK
HVGLF
HYE
HZ~
IHE
JIG
JSO
KQ8
LG5
LK8
M1P
M41
M7P
NCXOZ
NQ-
O9-
OK1
P2P
PQQKQ
PROAC
PSQYO
RCE
RIG
RNS
RNTTT
ROL
RPM
RPZ
SEW
SSZ
SV3
TR2
UHS
UKHRP
W2D
XPP
ZA5
ZMT
AAMRU
AAYWO
AAYXX
ABDGV
ABWVN
ACRPL
ACVFH
ADCNI
ADNMO
ADVLN
AEUPX
AFPUW
AGCQF
AIGII
AKAPO
AKBMS
AKRWK
AKYEP
ALIPV
APXCP
CITATION
PHGZM
PHGZT
CGR
CUY
CVF
ECM
EIF
NPM
7XB
8FK
AZQEC
DWQXO
EFKBS
GNUQQ
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PRINS
7X8
PUEGO
7QO
7T5
8FD
FR3
H94
P64
5PM
ID FETCH-LOGICAL-c4697-1f8a64bc8a6595b2347dc4d66f1559af10e7fdd9a56a6a687ea28a459dc711c3
IEDL.DBID 7X7
ISSN 1525-0016
IngestDate Thu Aug 21 14:12:04 EDT 2025
Thu Jul 10 22:40:40 EDT 2025
Sun Aug 24 03:45:57 EDT 2025
Fri Jul 25 11:08:18 EDT 2025
Wed Feb 19 02:40:04 EST 2025
Tue Jul 01 01:46:45 EDT 2025
Thu Apr 24 22:50:20 EDT 2025
Fri Feb 23 02:31:03 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 7
Language English
License http://creativecommons.org/licenses/by-nc-nd/4.0
https://www.elsevier.com/tdm/userlicense/1.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4697-1f8a64bc8a6595b2347dc4d66f1559af10e7fdd9a56a6a687ea28a459dc711c3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://dx.doi.org/10.1038/mt.2015.67
PMID 25899824
PQID 1791335748
PQPubID 2042164
PageCount 14
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_4817795
proquest_miscellaneous_1776654109
proquest_miscellaneous_1692753925
proquest_journals_1791335748
pubmed_primary_25899824
crossref_citationtrail_10_1038_mt_2015_67
crossref_primary_10_1038_mt_2015_67
elsevier_sciencedirect_doi_10_1038_mt_2015_67
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2015-07-01
PublicationDateYYYYMMDD 2015-07-01
PublicationDate_xml – month: 07
  year: 2015
  text: 2015-07-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Milwaukee
PublicationTitle Molecular therapy
PublicationTitleAlternate Mol Ther
PublicationYear 2015
Publisher Elsevier Inc
Elsevier Limited
Nature Publishing Group
Publisher_xml – name: Elsevier Inc
– name: Elsevier Limited
– name: Nature Publishing Group
References Chinnadurai, Waller, Galipeau, Nooka (bib44) 2013; 2013
Rioux, Xavier, Taylor, Silverberg, Goyette, Huett (bib22) 2007; 39
Galipeau (bib12) 2013; 15
Ma, Ning, Xu, Hou, Wang, Hou (bib14) 2013; 122
Tardito, Negrini, Conteduca, Ferrera, Parodi, Battaglia (bib20) 2013; 74
Bocelli-Tyndall, Bracci, Spagnoli, Braccini, Bouchenaki, Ceredig (bib17) 2007; 46
Horwitz, Le Blanc, Dominici, Mueller, Slaper-Cortenbach, Marini, International Society for Cellular Therapy (bib35) 2005; 7
Lassen, Kuballa, Conway, Patel, Becker, Peloquin (bib48) 2014; 111
Armaka, Apostolaki, Jacques, Kontoyiannis, Elewaut, Kollias (bib33) 2008; 205
Fujita, Saitoh, Kageyama, Akira, Noda, Yoshimori (bib49) 2009; 284
Schroepf, Kappler, Brand, Prell, Lohse, Glas (bib43) 2010; 16
Visscher, Brown, McCarthy, Yang (bib19) 2012; 90
Plantinga, Crisan, Oosting, van de Veerdonk, de Jong, Philpott (bib26) 2011; 60
Murthy, Li, Peng, Reichelt, Katakam, Noubade (bib47) 2014; 506
Nath, Arafat, Gibson (bib29) 2012; 3
Hampe, Franke, Rosenstiel, Till, Teuber, Huse (bib21) 2007; 39
Chinnadurai, Copland, Patel, Galipeau (bib28) 2014; 192
Murphy, Moncivais, Caplan (bib3) 2013; 45
Ren, Jin, Sabatino, Balakumaran, Feng, Kuznetsov (bib40) 2011; 13
Gianchecchi, Delfino, Fierabracci (bib24) 2014; 13
Rafei, Hsieh, Fortier, Li, Yuan, Birman (bib41) 2008; 112
François, Galipeau (bib10) 2012; 227
Chinnadurai, Garcia, Sakurai, Lam, Kirk, Galipeau (bib50) 2014; 3
François, Copland, Yuan, Romieu-Mourez, Waller, Galipeau (bib51) 2012; 14
Le Blanc, Mougiakakos (bib1) 2012; 12
François, Romieu-Mourez, Li, Galipeau (bib37) 2012; 20
Tang, Ma, Zhang, Gu, Hou, Gilkeson (bib15) 2012; 2012
Nys, Agostinis, Vermeire (bib25) 2013; 10
Moll, Alm, Davies, von Bahr, Heldring, Stenbeck-Funke (bib9) 2014; 32
Dominici, Le Blanc, Mueller, Slaper-Cortenbach, Marini, Krause (bib34) 2006; 8
Larghero, Farge, Braccini, Lecourt, Scherberich, Foïs (bib16) 2008; 67
Krampera, Galipeau, Shi, Tarte, Sensebe, MSC Committee of the International Society for Cellular Therapy (ISCT) (bib30) 2013; 15
Cadwell, Liu, Brown, Miyoshi, Loh, Lennerz (bib46) 2008; 456
Eliopoulos, Stagg, Lejeune, Pommey, Galipeau (bib8) 2005; 106
Romieu-Mourez, Coutu, Galipeau (bib39) 2012; 4
Saitoh, Fujita, Jang, Uematsu, Yang, Satoh (bib45) 2008; 456
Ren, Zhang, Zhao, Xu, Zhang, Roberts (bib31) 2008; 2
Rameshwar (bib11) 2009; 17
Powell, Pinchuk, Saada, Chen, Mifflin (bib32) 2011; 73
Voswinkel, Francois, Simon, Benderitter, Gorin, Mohty (bib7) 2013; 45
Lapaquette, Brest, Hofman, Darfeuille-Michaud (bib23) 2012; 90
Bernardo, Fibbe (bib2) 2013; 13
Papadaki, Kritikos, Gemetzi, Koutala, Marsh, Boumpas (bib13) 2002; 99
Romieu-Mourez, François, Boivin, Stagg, Galipeau (bib36) 2007; 179
Ricart, Jauregui-Amezaga, Ordás, Pinó, Ramírez, Panés (bib6) 2013; 14
Bernardo, Avanzini, Ciccocioppo, Perotti, Cometa, Moretta (bib18) 2009; 11
Copland, Garcia, Waller, Roback, Galipeau (bib27) 2013; 34
Forbes, Sturm, Leong, Sparrow, Segarajasingam, Cummins (bib5) 2014; 12
Duijvestein, Vos, Roelofs, Wildenberg, Wendrich, Verspaget (bib4) 2010; 59
Zenewicz, Antov, Flavell (bib38) 2009; 15
Cox, Dean, Roberts, Overall (bib42) 2008; 283
Ricart (10.1038/mt.2015.67_bib6) 2013; 14
Larghero (10.1038/mt.2015.67_bib16) 2008; 67
Bernardo (10.1038/mt.2015.67_bib18) 2009; 11
Dominici (10.1038/mt.2015.67_bib34) 2006; 8
François (10.1038/mt.2015.67_bib37) 2012; 20
Visscher (10.1038/mt.2015.67_bib19) 2012; 90
Papadaki (10.1038/mt.2015.67_bib13) 2002; 99
Forbes (10.1038/mt.2015.67_bib5) 2014; 12
Cadwell (10.1038/mt.2015.67_bib46) 2008; 456
Lassen (10.1038/mt.2015.67_bib48) 2014; 111
Fujita (10.1038/mt.2015.67_bib49) 2009; 284
Ren (10.1038/mt.2015.67_bib40) 2011; 13
Copland (10.1038/mt.2015.67_bib27) 2013; 34
Romieu-Mourez (10.1038/mt.2015.67_bib39) 2012; 4
Chinnadurai (10.1038/mt.2015.67_bib28) 2014; 192
Hampe (10.1038/mt.2015.67_bib21) 2007; 39
Gianchecchi (10.1038/mt.2015.67_bib24) 2014; 13
Moll (10.1038/mt.2015.67_bib9) 2014; 32
Chinnadurai (10.1038/mt.2015.67_bib44) 2013; 2013
Galipeau (10.1038/mt.2015.67_bib12) 2013; 15
Nys (10.1038/mt.2015.67_bib25) 2013; 10
Schroepf (10.1038/mt.2015.67_bib43) 2010; 16
Saitoh (10.1038/mt.2015.67_bib45) 2008; 456
Rafei (10.1038/mt.2015.67_bib41) 2008; 112
François (10.1038/mt.2015.67_bib10) 2012; 227
Tardito (10.1038/mt.2015.67_bib20) 2013; 74
Powell (10.1038/mt.2015.67_bib32) 2011; 73
Armaka (10.1038/mt.2015.67_bib33) 2008; 205
Bernardo (10.1038/mt.2015.67_bib2) 2013; 13
Rioux (10.1038/mt.2015.67_bib22) 2007; 39
Plantinga (10.1038/mt.2015.67_bib26) 2011; 60
Rameshwar (10.1038/mt.2015.67_bib11) 2009; 17
Ren (10.1038/mt.2015.67_bib31) 2008; 2
Murphy (10.1038/mt.2015.67_bib3) 2013; 45
Bocelli-Tyndall (10.1038/mt.2015.67_bib17) 2007; 46
Duijvestein (10.1038/mt.2015.67_bib4) 2010; 59
Chinnadurai (10.1038/mt.2015.67_bib50) 2014; 3
Krampera (10.1038/mt.2015.67_bib30) 2013; 15
Lapaquette (10.1038/mt.2015.67_bib23) 2012; 90
Romieu-Mourez (10.1038/mt.2015.67_bib36) 2007; 179
Eliopoulos (10.1038/mt.2015.67_bib8) 2005; 106
Cox (10.1038/mt.2015.67_bib42) 2008; 283
Le Blanc (10.1038/mt.2015.67_bib1) 2012; 12
Nath (10.1038/mt.2015.67_bib29) 2012; 3
Zenewicz (10.1038/mt.2015.67_bib38) 2009; 15
Tang (10.1038/mt.2015.67_bib15) 2012; 2012
Ma (10.1038/mt.2015.67_bib14) 2013; 122
Murthy (10.1038/mt.2015.67_bib47) 2014; 506
Voswinkel (10.1038/mt.2015.67_bib7) 2013; 45
Horwitz (10.1038/mt.2015.67_bib35) 2005; 7
François (10.1038/mt.2015.67_bib51) 2012; 14
18250193 - J Exp Med. 2008 Feb 18;205(2):331-7
16236628 - Cytotherapy. 2005;7(5):393-5
21250865 - Cytotherapy. 2011 Jul;13(6):661-74
20921206 - Gut. 2010 Dec;59(12):1662-9
22243964 - Am J Hum Genet. 2012 Jan 13;90(1):7-24
16923606 - Cytotherapy. 2006;8(4):315-7
16920750 - Rheumatology (Oxford). 2007 Mar;46(3):403-8
22378308 - J Cell Physiol. 2012 Nov;227(11):3535-8
16118325 - Blood. 2005 Dec 15;106(13):4057-65
17526552 - Ann Rheum Dis. 2008 Apr;67(4):443-9
18849965 - Nature. 2008 Nov 13;456(7219):264-8
24160439 - Curr Drug Targets. 2013 Nov;14(12):1453-9
21406388 - Gut. 2011 Sep;60(9):1229-35
24350294 - Biomed Res Int. 2013;2013:929842
18812467 - Blood. 2008 Dec 15;112(13):4991-8
23891515 - Biomaterials. 2013 Oct;34(32):7840-50
19783656 - J Biol Chem. 2009 Nov 20;284(47):32602-9
19180113 - Mol Ther. 2009 Feb;17(2):216-8
24805247 - Stem Cells. 2014 Sep;32(9):2430-42
24403533 - J Immunol. 2014 Feb 15;192(4):1491-501
11861275 - Blood. 2002 Mar 1;99(5):1610-9
17200669 - Nat Genet. 2007 Feb;39(2):207-11
24232253 - Exp Mol Med. 2013;45:e54
18411283 - J Biol Chem. 2008 Jul 11;283(28):19389-99
19362058 - Trends Mol Med. 2009 May;15(5):199-207
21054163 - Annu Rev Physiol. 2011;73:213-37
22029655 - Cytotherapy. 2012 Feb;14(2):147-52
23591407 - Nat Rev Gastroenterol Hepatol. 2013 Jul;10(7):395-401
17641021 - J Immunol. 2007 Aug 1;179(3):1549-58
25068122 - Stem Cell Reports. 2014 Jul 8;3(1):60-72
24553140 - Nature. 2014 Feb 27;506(7489):456-62
24094322 - Cell Stem Cell. 2013 Oct 3;13(4):392-402
23872668 - Clin Gastroenterol Hepatol. 2014 Jan;12(1):64-71
22797958 - J Mol Med (Berl). 2012 Sep;90(9):987-96
23926306 - Blood. 2013 Sep 19;122(12):2074-82
23200754 - Hum Immunol. 2013 Feb;74(2):166-9
23296948 - Clin Rev Allergy Immunol. 2013 Oct;45(2):180-92
22966240 - Clin Dev Immunol. 2012;2012:826182
18849966 - Nature. 2008 Nov 13;456(7219):259-63
19903096 - Cytotherapy. 2009;11(7):825-36
22201917 - Front Biosci (Elite Ed). 2012;4:824-37
18371435 - Cell Stem Cell. 2008 Feb 7;2(2):141-50
24821797 - Proc Natl Acad Sci U S A. 2014 May 27;111(21):7741-6
23602578 - Cytotherapy. 2013 Sep;15(9):1054-61
23162571 - Front Genet. 2012 Nov 09;3:243
17435756 - Nat Genet. 2007 May;39(5):596-604
24184881 - Autoimmun Rev. 2014 Mar;13(3):231-41
21934657 - Mol Ther. 2012 Jan;20(1):187-95
20848514 - Inflamm Bowel Dis. 2010 Nov;16(11):1882-90
23260081 - Cytotherapy. 2013 Jan;15(1):2-8
22531326 - Nat Rev Immunol. 2012 May;12(5):383-96
References_xml – volume: 46
  start-page: 403
  year: 2007
  end-page: 408
  ident: bib17
  article-title: Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes
  publication-title: Rheumatology (Oxford)
– volume: 74
  start-page: 166
  year: 2013
  end-page: 169
  ident: bib20
  article-title: Indoleamine 2,3 dioxygenase gene polymorphisms correlate with CD8+ Treg impairment in systemic sclerosis
  publication-title: Hum Immunol
– volume: 456
  start-page: 259
  year: 2008
  end-page: 263
  ident: bib46
  article-title: A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells
  publication-title: Nature
– volume: 106
  start-page: 4057
  year: 2005
  end-page: 4065
  ident: bib8
  article-title: Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice
  publication-title: Blood
– volume: 73
  start-page: 213
  year: 2011
  end-page: 237
  ident: bib32
  article-title: Mesenchymal cells of the intestinal lamina propria
  publication-title: Annu Rev Physiol
– volume: 34
  start-page: 7840
  year: 2013
  end-page: 7850
  ident: bib27
  article-title: The effect of platelet lysate fibrinogen on the functionality of MSCs in immunotherapy
  publication-title: Biomaterials
– volume: 179
  start-page: 1549
  year: 2007
  end-page: 1558
  ident: bib36
  article-title: Regulation of MHC class II expression and antigen processing in murine and human mesenchymal stromal cells by IFN-gamma, TGF-beta, and cell density
  publication-title: J Immunol
– volume: 12
  start-page: 64
  year: 2014
  end-page: 71
  ident: bib5
  article-title: A phase 2 study of allogeneic mesenchymal stromal cells for luminal Crohn's disease refractory to biologic therapy
  publication-title: Clin Gastroenterol Hepatol
– volume: 60
  start-page: 1229
  year: 2011
  end-page: 1235
  ident: bib26
  article-title: Crohn's disease-associated ATG16L1 polymorphism modulates pro-inflammatory cytokine responses selectively upon activation of NOD2
  publication-title: Gut
– volume: 15
  start-page: 199
  year: 2009
  end-page: 207
  ident: bib38
  article-title: CD4 T-cell differentiation and inflammatory bowel disease
  publication-title: Trends Mol Med
– volume: 14
  start-page: 1453
  year: 2013
  end-page: 1459
  ident: bib6
  article-title: Cell therapies for IBD: what works?
  publication-title: Curr Drug Targets
– volume: 17
  start-page: 216
  year: 2009
  end-page: 218
  ident: bib11
  article-title: Casting doubt on the safety of “off-the-shelf” mesenchymal stem cells for cell therapy
  publication-title: Mol Ther
– volume: 2012
  start-page: 826182
  year: 2012
  ident: bib15
  article-title: Gene expression profile reveals abnormalities of multiple signaling pathways in mesenchymal stem cell derived from patients with systemic lupus erythematosus
  publication-title: Clin Dev Immunol
– volume: 13
  start-page: 392
  year: 2013
  end-page: 402
  ident: bib2
  article-title: Mesenchymal stromal cells: sensors and switchers of inflammation
  publication-title: Cell Stem Cell
– volume: 7
  start-page: 393
  year: 2005
  end-page: 395
  ident: bib35
  article-title: Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement
  publication-title: Cytotherapy
– volume: 99
  start-page: 1610
  year: 2002
  end-page: 1619
  ident: bib13
  article-title: Bone marrow progenitor cell reserve and function and stromal cell function are defective in rheumatoid arthritis: evidence for a tumor necrosis factor alpha-mediated effect
  publication-title: Blood
– volume: 45
  start-page: e54
  year: 2013
  ident: bib3
  article-title: Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine
  publication-title: Exp Mol Med
– volume: 13
  start-page: 231
  year: 2014
  end-page: 241
  ident: bib24
  article-title: Recent insights on the putative role of autophagy in autoimmune diseases
  publication-title: Autoimmun Rev
– volume: 192
  start-page: 1491
  year: 2014
  end-page: 1501
  ident: bib28
  article-title: IDO-independent suppression of T cell effector function by IFN-γ-licensed human mesenchymal stromal cells
  publication-title: J Immunol
– volume: 90
  start-page: 7
  year: 2012
  end-page: 24
  ident: bib19
  article-title: Five years of GWAS discovery
  publication-title: Am J Hum Genet
– volume: 506
  start-page: 456
  year: 2014
  end-page: 462
  ident: bib47
  article-title: A Crohn's disease variant in Atg16l1 enhances its degradation by caspase 3
  publication-title: Nature
– volume: 111
  start-page: 7741
  year: 2014
  end-page: 7746
  ident: bib48
  article-title: Atg16L1 T300A variant decreases selective autophagy resulting in altered cytokine signaling and decreased antibacterial defense
  publication-title: Proc Natl Acad Sci U S A
– volume: 122
  start-page: 2074
  year: 2013
  end-page: 2082
  ident: bib14
  article-title: Thalidomide corrects impaired mesenchymal stem cell function in inducing tolerogenic DCs in patients with immune thrombocytopenia
  publication-title: Blood
– volume: 15
  start-page: 1054
  year: 2013
  end-page: 1061
  ident: bib30
  article-title: Immunological characterization of multipotent mesenchymal stromal cells–The International Society for Cellular Therapy (ISCT) working proposal
  publication-title: Cytotherapy
– volume: 2
  start-page: 141
  year: 2008
  end-page: 150
  ident: bib31
  article-title: Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide
  publication-title: Cell Stem Cell
– volume: 11
  start-page: 825
  year: 2009
  end-page: 836
  ident: bib18
  article-title: Phenotypical/functional characterization of
  publication-title: Cytotherapy
– volume: 3
  start-page: 60
  year: 2014
  end-page: 72
  ident: bib50
  article-title: Actin cytoskeletal disruption following cryopreservation alters the biodistribution of human mesenchymal stromal cells in vivo
  publication-title: Stem Cell Reports
– volume: 16
  start-page: 1882
  year: 2010
  end-page: 1890
  ident: bib43
  article-title: Strong overexpression of CXCR3 axis components in childhood inflammatory bowel disease
  publication-title: Inflamm Bowel Dis
– volume: 8
  start-page: 315
  year: 2006
  end-page: 317
  ident: bib34
  article-title: Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement
  publication-title: Cytotherapy
– volume: 3
  start-page: 243
  year: 2012
  ident: bib29
  article-title: Using blood informative transcripts in geographical genomics: impact of lifestyle on gene expression in fijians
  publication-title: Front Genet
– volume: 15
  start-page: 2
  year: 2013
  end-page: 8
  ident: bib12
  article-title: The mesenchymal stromal cells dilemma–does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road?
  publication-title: Cytotherapy
– volume: 39
  start-page: 596
  year: 2007
  end-page: 604
  ident: bib22
  article-title: Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis
  publication-title: Nat Genet
– volume: 227
  start-page: 3535
  year: 2012
  end-page: 3538
  ident: bib10
  article-title: New insights on translational development of mesenchymal stromal cells for suppressor therapy
  publication-title: J Cell Physiol
– volume: 205
  start-page: 331
  year: 2008
  end-page: 337
  ident: bib33
  article-title: Mesenchymal cell targeting by TNF as a common pathogenic principle in chronic inflammatory joint and intestinal diseases
  publication-title: J Exp Med
– volume: 67
  start-page: 443
  year: 2008
  end-page: 449
  ident: bib16
  article-title: Phenotypical and functional characteristics of
  publication-title: Ann Rheum Dis
– volume: 4
  start-page: 824
  year: 2012
  end-page: 837
  ident: bib39
  article-title: The immune plasticity of mesenchymal stromal cells from mice and men: concordances and discrepancies
  publication-title: Front Biosci (Elite Ed)
– volume: 39
  start-page: 207
  year: 2007
  end-page: 211
  ident: bib21
  article-title: A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1
  publication-title: Nat Genet
– volume: 284
  start-page: 32602
  year: 2009
  end-page: 32609
  ident: bib49
  article-title: Differential involvement of Atg16L1 in Crohn disease and canonical autophagy: analysis of the organization of the Atg16L1 complex in fibroblasts
  publication-title: J Biol Chem
– volume: 45
  start-page: 180
  year: 2013
  end-page: 192
  ident: bib7
  article-title: Use of mesenchymal stem cells (MSC) in chronic inflammatory fistulizing and fibrotic diseases: a comprehensive review
  publication-title: Clin Rev Allergy Immunol
– volume: 456
  start-page: 264
  year: 2008
  end-page: 268
  ident: bib45
  article-title: Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production
  publication-title: Nature
– volume: 112
  start-page: 4991
  year: 2008
  end-page: 4998
  ident: bib41
  article-title: Mesenchymal stromal cell-derived CCL2 suppresses plasma cell immunoglobulin production via STAT3 inactivation and PAX5 induction
  publication-title: Blood
– volume: 13
  start-page: 661
  year: 2011
  end-page: 674
  ident: bib40
  article-title: Global transcriptome analysis of human bone marrow stromal cells (BMSC) reveals proliferative, mobile and interactive cells that produce abundant extracellular matrix proteins, some of which may affect BMSC potency
  publication-title: Cytotherapy
– volume: 90
  start-page: 987
  year: 2012
  end-page: 996
  ident: bib23
  article-title: Etiology of Crohn's disease: many roads lead to autophagy
  publication-title: J Mol Med (Berl)
– volume: 283
  start-page: 19389
  year: 2008
  end-page: 19399
  ident: bib42
  article-title: Matrix metalloproteinase processing of CXCL11/I-TAC results in loss of chemoattractant activity and altered glycosaminoglycan binding
  publication-title: J Biol Chem
– volume: 20
  start-page: 187
  year: 2012
  end-page: 195
  ident: bib37
  article-title: Human MSC suppression correlates with cytokine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiation
  publication-title: Mol Ther
– volume: 10
  start-page: 395
  year: 2013
  end-page: 401
  ident: bib25
  article-title: Autophagy: a new target or an old strategy for the treatment of Crohn's disease?
  publication-title: Nat Rev Gastroenterol Hepatol
– volume: 2013
  start-page: 929842
  year: 2013
  ident: bib44
  article-title: From single nucleotide polymorphisms to constant immunosuppression: mesenchymal stem cell therapy for autoimmune diseases
  publication-title: Biomed Res Int
– volume: 12
  start-page: 383
  year: 2012
  end-page: 396
  ident: bib1
  article-title: Multipotent mesenchymal stromal cells and the innate immune system
  publication-title: Nat Rev Immunol
– volume: 59
  start-page: 1662
  year: 2010
  end-page: 1669
  ident: bib4
  article-title: Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study
  publication-title: Gut
– volume: 32
  start-page: 2430
  year: 2014
  end-page: 2442
  ident: bib9
  article-title: Do cryopreserved mesenchymal stromal cells display impaired immunomodulatory and therapeutic properties?
  publication-title: Stem Cells
– volume: 14
  start-page: 147
  year: 2012
  end-page: 152
  ident: bib51
  article-title: Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-γ licensing
  publication-title: Cytotherapy
– volume: 3
  start-page: 243
  year: 2012
  ident: 10.1038/mt.2015.67_bib29
  article-title: Using blood informative transcripts in geographical genomics: impact of lifestyle on gene expression in fijians
  publication-title: Front Genet
  doi: 10.3389/fgene.2012.00243
– volume: 11
  start-page: 825
  year: 2009
  ident: 10.1038/mt.2015.67_bib18
  article-title: Phenotypical/functional characterization of in vitro-expanded mesenchymal stromal cells from patients with Crohn's disease
  publication-title: Cytotherapy
  doi: 10.3109/14653240903121260
– volume: 4
  start-page: 824
  year: 2012
  ident: 10.1038/mt.2015.67_bib39
  article-title: The immune plasticity of mesenchymal stromal cells from mice and men: concordances and discrepancies
  publication-title: Front Biosci (Elite Ed)
– volume: 122
  start-page: 2074
  year: 2013
  ident: 10.1038/mt.2015.67_bib14
  article-title: Thalidomide corrects impaired mesenchymal stem cell function in inducing tolerogenic DCs in patients with immune thrombocytopenia
  publication-title: Blood
  doi: 10.1182/blood-2013-03-491555
– volume: 12
  start-page: 64
  year: 2014
  ident: 10.1038/mt.2015.67_bib5
  article-title: A phase 2 study of allogeneic mesenchymal stromal cells for luminal Crohn's disease refractory to biologic therapy
  publication-title: Clin Gastroenterol Hepatol
  doi: 10.1016/j.cgh.2013.06.021
– volume: 227
  start-page: 3535
  year: 2012
  ident: 10.1038/mt.2015.67_bib10
  article-title: New insights on translational development of mesenchymal stromal cells for suppressor therapy
  publication-title: J Cell Physiol
  doi: 10.1002/jcp.24081
– volume: 111
  start-page: 7741
  year: 2014
  ident: 10.1038/mt.2015.67_bib48
  article-title: Atg16L1 T300A variant decreases selective autophagy resulting in altered cytokine signaling and decreased antibacterial defense
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.1407001111
– volume: 284
  start-page: 32602
  year: 2009
  ident: 10.1038/mt.2015.67_bib49
  article-title: Differential involvement of Atg16L1 in Crohn disease and canonical autophagy: analysis of the organization of the Atg16L1 complex in fibroblasts
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M109.037671
– volume: 10
  start-page: 395
  year: 2013
  ident: 10.1038/mt.2015.67_bib25
  article-title: Autophagy: a new target or an old strategy for the treatment of Crohn's disease?
  publication-title: Nat Rev Gastroenterol Hepatol
  doi: 10.1038/nrgastro.2013.66
– volume: 90
  start-page: 987
  year: 2012
  ident: 10.1038/mt.2015.67_bib23
  article-title: Etiology of Crohn's disease: many roads lead to autophagy
  publication-title: J Mol Med (Berl)
  doi: 10.1007/s00109-012-0934-8
– volume: 13
  start-page: 231
  year: 2014
  ident: 10.1038/mt.2015.67_bib24
  article-title: Recent insights on the putative role of autophagy in autoimmune diseases
  publication-title: Autoimmun Rev
  doi: 10.1016/j.autrev.2013.10.007
– volume: 15
  start-page: 199
  year: 2009
  ident: 10.1038/mt.2015.67_bib38
  article-title: CD4 T-cell differentiation and inflammatory bowel disease
  publication-title: Trends Mol Med
  doi: 10.1016/j.molmed.2009.03.002
– volume: 15
  start-page: 2
  year: 2013
  ident: 10.1038/mt.2015.67_bib12
  article-title: The mesenchymal stromal cells dilemma–does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road?
  publication-title: Cytotherapy
  doi: 10.1016/j.jcyt.2012.10.002
– volume: 45
  start-page: e54
  year: 2013
  ident: 10.1038/mt.2015.67_bib3
  article-title: Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine
  publication-title: Exp Mol Med
  doi: 10.1038/emm.2013.94
– volume: 456
  start-page: 264
  year: 2008
  ident: 10.1038/mt.2015.67_bib45
  article-title: Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production
  publication-title: Nature
  doi: 10.1038/nature07383
– volume: 20
  start-page: 187
  year: 2012
  ident: 10.1038/mt.2015.67_bib37
  article-title: Human MSC suppression correlates with cytokine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiation
  publication-title: Mol Ther
  doi: 10.1038/mt.2011.189
– volume: 32
  start-page: 2430
  year: 2014
  ident: 10.1038/mt.2015.67_bib9
  article-title: Do cryopreserved mesenchymal stromal cells display impaired immunomodulatory and therapeutic properties?
  publication-title: Stem Cells
  doi: 10.1002/stem.1729
– volume: 283
  start-page: 19389
  year: 2008
  ident: 10.1038/mt.2015.67_bib42
  article-title: Matrix metalloproteinase processing of CXCL11/I-TAC results in loss of chemoattractant activity and altered glycosaminoglycan binding
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M800266200
– volume: 45
  start-page: 180
  year: 2013
  ident: 10.1038/mt.2015.67_bib7
  article-title: Use of mesenchymal stem cells (MSC) in chronic inflammatory fistulizing and fibrotic diseases: a comprehensive review
  publication-title: Clin Rev Allergy Immunol
  doi: 10.1007/s12016-012-8347-6
– volume: 13
  start-page: 661
  year: 2011
  ident: 10.1038/mt.2015.67_bib40
  article-title: Global transcriptome analysis of human bone marrow stromal cells (BMSC) reveals proliferative, mobile and interactive cells that produce abundant extracellular matrix proteins, some of which may affect BMSC potency
  publication-title: Cytotherapy
  doi: 10.3109/14653249.2010.548379
– volume: 12
  start-page: 383
  year: 2012
  ident: 10.1038/mt.2015.67_bib1
  article-title: Multipotent mesenchymal stromal cells and the innate immune system
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri3209
– volume: 112
  start-page: 4991
  year: 2008
  ident: 10.1038/mt.2015.67_bib41
  article-title: Mesenchymal stromal cell-derived CCL2 suppresses plasma cell immunoglobulin production via STAT3 inactivation and PAX5 induction
  publication-title: Blood
  doi: 10.1182/blood-2008-07-166892
– volume: 8
  start-page: 315
  year: 2006
  ident: 10.1038/mt.2015.67_bib34
  article-title: Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement
  publication-title: Cytotherapy
  doi: 10.1080/14653240600855905
– volume: 99
  start-page: 1610
  year: 2002
  ident: 10.1038/mt.2015.67_bib13
  article-title: Bone marrow progenitor cell reserve and function and stromal cell function are defective in rheumatoid arthritis: evidence for a tumor necrosis factor alpha-mediated effect
  publication-title: Blood
  doi: 10.1182/blood.V99.5.1610
– volume: 15
  start-page: 1054
  year: 2013
  ident: 10.1038/mt.2015.67_bib30
  article-title: Immunological characterization of multipotent mesenchymal stromal cells–The International Society for Cellular Therapy (ISCT) working proposal
  publication-title: Cytotherapy
  doi: 10.1016/j.jcyt.2013.02.010
– volume: 2
  start-page: 141
  year: 2008
  ident: 10.1038/mt.2015.67_bib31
  article-title: Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide
  publication-title: Cell Stem Cell
  doi: 10.1016/j.stem.2007.11.014
– volume: 2013
  start-page: 929842
  year: 2013
  ident: 10.1038/mt.2015.67_bib44
  article-title: From single nucleotide polymorphisms to constant immunosuppression: mesenchymal stem cell therapy for autoimmune diseases
  publication-title: Biomed Res Int
  doi: 10.1155/2013/929842
– volume: 14
  start-page: 1453
  year: 2013
  ident: 10.1038/mt.2015.67_bib6
  article-title: Cell therapies for IBD: what works?
  publication-title: Curr Drug Targets
  doi: 10.2174/13894501113146660234
– volume: 73
  start-page: 213
  year: 2011
  ident: 10.1038/mt.2015.67_bib32
  article-title: Mesenchymal cells of the intestinal lamina propria
  publication-title: Annu Rev Physiol
  doi: 10.1146/annurev.physiol.70.113006.100646
– volume: 506
  start-page: 456
  year: 2014
  ident: 10.1038/mt.2015.67_bib47
  article-title: A Crohn's disease variant in Atg16l1 enhances its degradation by caspase 3
  publication-title: Nature
  doi: 10.1038/nature13044
– volume: 90
  start-page: 7
  year: 2012
  ident: 10.1038/mt.2015.67_bib19
  article-title: Five years of GWAS discovery
  publication-title: Am J Hum Genet
  doi: 10.1016/j.ajhg.2011.11.029
– volume: 13
  start-page: 392
  year: 2013
  ident: 10.1038/mt.2015.67_bib2
  article-title: Mesenchymal stromal cells: sensors and switchers of inflammation
  publication-title: Cell Stem Cell
  doi: 10.1016/j.stem.2013.09.006
– volume: 67
  start-page: 443
  year: 2008
  ident: 10.1038/mt.2015.67_bib16
  article-title: Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.2007.071233
– volume: 179
  start-page: 1549
  year: 2007
  ident: 10.1038/mt.2015.67_bib36
  article-title: Regulation of MHC class II expression and antigen processing in murine and human mesenchymal stromal cells by IFN-gamma, TGF-beta, and cell density
  publication-title: J Immunol
  doi: 10.4049/jimmunol.179.3.1549
– volume: 39
  start-page: 596
  year: 2007
  ident: 10.1038/mt.2015.67_bib22
  article-title: Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis
  publication-title: Nat Genet
  doi: 10.1038/ng2032
– volume: 59
  start-page: 1662
  year: 2010
  ident: 10.1038/mt.2015.67_bib4
  article-title: Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study
  publication-title: Gut
  doi: 10.1136/gut.2010.215152
– volume: 60
  start-page: 1229
  year: 2011
  ident: 10.1038/mt.2015.67_bib26
  article-title: Crohn's disease-associated ATG16L1 polymorphism modulates pro-inflammatory cytokine responses selectively upon activation of NOD2
  publication-title: Gut
  doi: 10.1136/gut.2010.228908
– volume: 192
  start-page: 1491
  year: 2014
  ident: 10.1038/mt.2015.67_bib28
  article-title: IDO-independent suppression of T cell effector function by IFN-γ-licensed human mesenchymal stromal cells
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1301828
– volume: 3
  start-page: 60
  year: 2014
  ident: 10.1038/mt.2015.67_bib50
  article-title: Actin cytoskeletal disruption following cryopreservation alters the biodistribution of human mesenchymal stromal cells in vivo
  publication-title: Stem Cell Reports
  doi: 10.1016/j.stemcr.2014.05.003
– volume: 2012
  start-page: 826182
  year: 2012
  ident: 10.1038/mt.2015.67_bib15
  article-title: Gene expression profile reveals abnormalities of multiple signaling pathways in mesenchymal stem cell derived from patients with systemic lupus erythematosus
  publication-title: Clin Dev Immunol
  doi: 10.1155/2012/826182
– volume: 46
  start-page: 403
  year: 2007
  ident: 10.1038/mt.2015.67_bib17
  article-title: Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro
  publication-title: Rheumatology (Oxford)
  doi: 10.1093/rheumatology/kel267
– volume: 456
  start-page: 259
  year: 2008
  ident: 10.1038/mt.2015.67_bib46
  article-title: A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells
  publication-title: Nature
  doi: 10.1038/nature07416
– volume: 17
  start-page: 216
  year: 2009
  ident: 10.1038/mt.2015.67_bib11
  article-title: Casting doubt on the safety of “off-the-shelf” mesenchymal stem cells for cell therapy
  publication-title: Mol Ther
  doi: 10.1038/mt.2008.296
– volume: 205
  start-page: 331
  year: 2008
  ident: 10.1038/mt.2015.67_bib33
  article-title: Mesenchymal cell targeting by TNF as a common pathogenic principle in chronic inflammatory joint and intestinal diseases
  publication-title: J Exp Med
  doi: 10.1084/jem.20070906
– volume: 14
  start-page: 147
  year: 2012
  ident: 10.1038/mt.2015.67_bib51
  article-title: Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-γ licensing
  publication-title: Cytotherapy
  doi: 10.3109/14653249.2011.623691
– volume: 7
  start-page: 393
  year: 2005
  ident: 10.1038/mt.2015.67_bib35
  article-title: Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement
  publication-title: Cytotherapy
  doi: 10.1080/14653240500319234
– volume: 74
  start-page: 166
  year: 2013
  ident: 10.1038/mt.2015.67_bib20
  article-title: Indoleamine 2,3 dioxygenase gene polymorphisms correlate with CD8+ Treg impairment in systemic sclerosis
  publication-title: Hum Immunol
  doi: 10.1016/j.humimm.2012.11.008
– volume: 34
  start-page: 7840
  year: 2013
  ident: 10.1038/mt.2015.67_bib27
  article-title: The effect of platelet lysate fibrinogen on the functionality of MSCs in immunotherapy
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2013.06.050
– volume: 16
  start-page: 1882
  year: 2010
  ident: 10.1038/mt.2015.67_bib43
  article-title: Strong overexpression of CXCR3 axis components in childhood inflammatory bowel disease
  publication-title: Inflamm Bowel Dis
  doi: 10.1002/ibd.21312
– volume: 106
  start-page: 4057
  year: 2005
  ident: 10.1038/mt.2015.67_bib8
  article-title: Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice
  publication-title: Blood
  doi: 10.1182/blood-2005-03-1004
– volume: 39
  start-page: 207
  year: 2007
  ident: 10.1038/mt.2015.67_bib21
  article-title: A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1
  publication-title: Nat Genet
  doi: 10.1038/ng1954
– reference: 18371435 - Cell Stem Cell. 2008 Feb 7;2(2):141-50
– reference: 24160439 - Curr Drug Targets. 2013 Nov;14(12):1453-9
– reference: 23872668 - Clin Gastroenterol Hepatol. 2014 Jan;12(1):64-71
– reference: 22531326 - Nat Rev Immunol. 2012 May;12(5):383-96
– reference: 17435756 - Nat Genet. 2007 May;39(5):596-604
– reference: 19783656 - J Biol Chem. 2009 Nov 20;284(47):32602-9
– reference: 18849966 - Nature. 2008 Nov 13;456(7219):259-63
– reference: 23260081 - Cytotherapy. 2013 Jan;15(1):2-8
– reference: 22378308 - J Cell Physiol. 2012 Nov;227(11):3535-8
– reference: 24553140 - Nature. 2014 Feb 27;506(7489):456-62
– reference: 25068122 - Stem Cell Reports. 2014 Jul 8;3(1):60-72
– reference: 24821797 - Proc Natl Acad Sci U S A. 2014 May 27;111(21):7741-6
– reference: 16920750 - Rheumatology (Oxford). 2007 Mar;46(3):403-8
– reference: 21054163 - Annu Rev Physiol. 2011;73:213-37
– reference: 22797958 - J Mol Med (Berl). 2012 Sep;90(9):987-96
– reference: 22966240 - Clin Dev Immunol. 2012;2012:826182
– reference: 16923606 - Cytotherapy. 2006;8(4):315-7
– reference: 20848514 - Inflamm Bowel Dis. 2010 Nov;16(11):1882-90
– reference: 24350294 - Biomed Res Int. 2013;2013:929842
– reference: 11861275 - Blood. 2002 Mar 1;99(5):1610-9
– reference: 18849965 - Nature. 2008 Nov 13;456(7219):264-8
– reference: 22243964 - Am J Hum Genet. 2012 Jan 13;90(1):7-24
– reference: 18411283 - J Biol Chem. 2008 Jul 11;283(28):19389-99
– reference: 22201917 - Front Biosci (Elite Ed). 2012;4:824-37
– reference: 17200669 - Nat Genet. 2007 Feb;39(2):207-11
– reference: 24232253 - Exp Mol Med. 2013;45:e54
– reference: 23591407 - Nat Rev Gastroenterol Hepatol. 2013 Jul;10(7):395-401
– reference: 24094322 - Cell Stem Cell. 2013 Oct 3;13(4):392-402
– reference: 24184881 - Autoimmun Rev. 2014 Mar;13(3):231-41
– reference: 19362058 - Trends Mol Med. 2009 May;15(5):199-207
– reference: 24403533 - J Immunol. 2014 Feb 15;192(4):1491-501
– reference: 22029655 - Cytotherapy. 2012 Feb;14(2):147-52
– reference: 21250865 - Cytotherapy. 2011 Jul;13(6):661-74
– reference: 18812467 - Blood. 2008 Dec 15;112(13):4991-8
– reference: 20921206 - Gut. 2010 Dec;59(12):1662-9
– reference: 23602578 - Cytotherapy. 2013 Sep;15(9):1054-61
– reference: 24805247 - Stem Cells. 2014 Sep;32(9):2430-42
– reference: 23891515 - Biomaterials. 2013 Oct;34(32):7840-50
– reference: 21406388 - Gut. 2011 Sep;60(9):1229-35
– reference: 17526552 - Ann Rheum Dis. 2008 Apr;67(4):443-9
– reference: 18250193 - J Exp Med. 2008 Feb 18;205(2):331-7
– reference: 23296948 - Clin Rev Allergy Immunol. 2013 Oct;45(2):180-92
– reference: 19180113 - Mol Ther. 2009 Feb;17(2):216-8
– reference: 16236628 - Cytotherapy. 2005;7(5):393-5
– reference: 19903096 - Cytotherapy. 2009;11(7):825-36
– reference: 23200754 - Hum Immunol. 2013 Feb;74(2):166-9
– reference: 17641021 - J Immunol. 2007 Aug 1;179(3):1549-58
– reference: 23926306 - Blood. 2013 Sep 19;122(12):2074-82
– reference: 23162571 - Front Genet. 2012 Nov 09;3:243
– reference: 21934657 - Mol Ther. 2012 Jan;20(1):187-95
– reference: 16118325 - Blood. 2005 Dec 15;106(13):4057-65
SSID ssj0011596
Score 2.3814728
Snippet Autologous bone marrow-derived mesenchymal stromal cells (MSCs) for adoptive cell therapy of luminal Crohn's disease (CD) are being tested in clinical trials....
SourceID pubmedcentral
proquest
pubmed
crossref
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1248
SubjectTerms Autophagy
Autophagy - immunology
Bone marrow
Bone Marrow Cells
Cell Proliferation - genetics
Clinical trials
Coculture Techniques
Crohn Disease - genetics
Crohn Disease - immunology
Crohn Disease - pathology
Crohn's disease
Genotype & phenotype
Hematology
Humans
Immunosuppression
Indoleamine-Pyrrole 2,3,-Dioxygenase - biosynthesis
Indoleamine-Pyrrole 2,3,-Dioxygenase - genetics
Indoleamine-Pyrrole 2,3,-Dioxygenase - immunology
Interferon-gamma - biosynthesis
Interferon-gamma - genetics
Interferon-gamma - immunology
Lymphocyte Activation - immunology
Mesenchymal Stromal Cells - immunology
Mesenchymal Stromal Cells - pathology
Oncology
Original
Polymorphism
T-Lymphocytes - immunology
Title Mesenchymal Stromal Cells Derived From Crohn's Patients Deploy Indoleamine 2,3-dioxygenase-mediated Immune Suppression, Independent of Autophagy
URI https://dx.doi.org/10.1038/mt.2015.67
https://www.ncbi.nlm.nih.gov/pubmed/25899824
https://www.proquest.com/docview/1791335748
https://www.proquest.com/docview/1692753925
https://www.proquest.com/docview/1776654109
https://pubmed.ncbi.nlm.nih.gov/PMC4817795
Volume 23
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1tb9MwELZgE4gvCMZbYExGICGkeWsSO7Y_odGtWkGdJhhSv0WO49BJbTLaFNF_wU_mLnEDg2qKlCjxJUp059zZd34eQt7YUGdG9QzLokQx8NecaS4KZlRswNvrUDuc0B-dJadf-cexGPsJt4Uvq1z_E5sfdV5ZnCM_RBjNOBaSq_dX3xmyRmF21VNo3CbbCF2GVi3H3YALgp2GnwspfhjGNmt40lgdzrCOMhQHDb_8Rof0f8D5b93kX45o8IDc9xEkPWpV_pDccuUOudNySq52yN2Rz5Y_Ir9GuLTITlYzkP9Szys89t10uqDHYHg_XE4HcJH259WkfLug5y3GKrYiDTAdlgj3ZGbwMBrtxyy_rH6uwODA8bFmxQlEq3SIC0wcRXbQtqS23McbPbduTauCHi0RvcB8Wz0mF4OTi_4p8wwMzMKwWbKwUCbhmYW90CIDTcrc8jxJCsxmmiLsOVnkuTYiMbAp6UykDBc6tzIMbfyEbJVV6Z4RmnNkSXJhAY28KCKjklgKkYVwTxRbF5B3ay2k1qOTI0nGNG2y5LFKZ3WKGksTGZDXnexVi8mxUYqtlZn6aKKNElJwFhvld9caT30_XqR_rC4gr7pm6IGYVjGlq5Ygk-gIBn06EjfISIk0z2FPB-Rpa0Tdq0cCx7wRD4i8Zl6dACKAX28pLycNEjhX8GAtnt_86i_IPfzGtsh4l2zV86V7CaFUne01_WWPbH84OTv_DGfHw0-_AYxaImk
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1tb9MwELbGEC9fEIy3wgAjQAhpZo1jx_YHhKaOqWXrhEQn9ZvlJA6d1CajL0D_BX-E_8hdXgqDat-mSIkUXyxHd_bd-c73EPIyCUzsdNuxmEeagb4WzAiZMadDB9reBMbjhn7_OOqeiI9DOdwgv5qzMJhW2ayJ5UKdFgnuke9iGc0wlEro92dfGaJGYXS1gdCoxOLQL7-DyzZ719sH_r7i_ODDoNNlNaoAS8AVVCzItItEnMBdGhnD6FSaiDSKMozQuSxoe5WlqXEycnBp5R3XTkiTJioIkhC6vUKugt5to6-nhiv_DmyrEg4MEYUYmlJNNdRQ704wbTOQb0s4-7X673_79t80zb_03sFtcqs2WOleJWF3yIbPt8i1CsJyuUWu9-vg_F3ys48nmZLRcgL0n-fTAp8dPx7P6D7I-Tef0gN4STvTYpS_ntFPVUlXbEXUYdrLsbqUm0BnlO-ELD0tfixBvkHPsvKACxjHtIfnWTxFMNIqgzffwQ9rKN85LTK6t8BiCe7L8h4ZXAZr7pPNvMj9Q0JTgaBMPsigUWQZdzoKlZRxAN_wMPEt8qbhgk3qYuiIyTG2ZVA-1HYyt8gxG6kWebGiPatKgKylYg0zbW28VEaJBd20ln674bitl42Z_SPkLfJ81QwTHqM4LvfFAmgiw8HHNFxeQKMUokoHbdMiDyohWg2dS3SxuWgRdU68VgRYcPx8S346KguPCw0dG_no4qE_Ize6g_6RPeodHz4mN_F_q_zmbbI5ny78E7Di5vHTcu5QYi95rv4GZ8VcIQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Mesenchymal+Stromal+Cells+Derived+From+Crohn%27s+Patients+Deploy+Indoleamine+2%2C3-dioxygenase-mediated+Immune+Suppression%2C+Independent+of+Autophagy&rft.jtitle=Molecular+therapy&rft.au=Chinnadurai%2C+Raghavan&rft.au=Copland%2C+Ian+B&rft.au=Ng%2C+Spencer&rft.au=Garcia%2C+Marco&rft.date=2015-07-01&rft.pub=Nature+Publishing+Group&rft.issn=1525-0016&rft.eissn=1525-0024&rft.volume=23&rft.issue=7&rft.spage=1248&rft.epage=1261&rft_id=info:doi/10.1038%2Fmt.2015.67&rft_id=info%3Apmid%2F25899824&rft.externalDocID=PMC4817795
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1525-0016&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1525-0016&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1525-0016&client=summon